Harte Hanks Inc (HHS) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is significantly deteriorating, with sharp declines in revenue, net income, and EPS. Additionally, there are no positive trading trends, news catalysts, or proprietary trading signals to support a buy decision. The technical analysis indicates a bearish trend, and there is no recent activity from influential figures or Congress to suggest confidence in the stock.

Technical Analysis

The MACD is slightly positive and expanding, but the RSI is neutral, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.869, with resistance at 3.014 and support at 2.723. Overall, the technical indicators do not suggest a strong buy signal.

Positive Catalysts

NULL identified. No recent news, trading trends, or proprietary trading signals to support a positive outlook.

Neutral/Negative Catalysts

Significant deterioration in financial performance, including a 17.03% YoY revenue drop, a 1709.86% YoY decline in net income, and a 1650% YoY decline in EPS. Gross margin has also decreased. No positive trading trends or news catalysts.

Financial Performance

In Q3 2025, Harte Hanks Inc reported a 17.03% YoY revenue decline to $39,520,000. Net income dropped to -$2,286,000, a 1709.86% YoY decline, and EPS fell to -0.31, down 1650% YoY. Gross margin decreased to 15.68%, down 6.56% YoY. The financial performance is significantly negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available on analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast HHS stock price to rise

Buy

Hold

Sell

Current: 2.750

Low

Averages

High